Cooper Companies Inc (COO) Shares Sold by Eaton Vance Management
Eaton Vance Management lowered its position in Cooper Companies Inc (NYSE:COO) by 87.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,295 shares of the medical device company’s stock after selling 51,821 shares during the quarter. Eaton Vance Management’s holdings in Cooper Companies were worth $1,589,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in the stock. BlackRock Inc. grew its stake in Cooper Companies by 1.5% in the fourth quarter. BlackRock Inc. now owns 3,616,339 shares of the medical device company’s stock worth $787,926,000 after purchasing an additional 54,380 shares in the last quarter. Janus Henderson Group PLC grew its stake in Cooper Companies by 0.4% in the third quarter. Janus Henderson Group PLC now owns 2,185,268 shares of the medical device company’s stock worth $518,147,000 after purchasing an additional 9,477 shares in the last quarter. Amundi Pioneer Asset Management Inc. grew its stake in Cooper Companies by 2.2% in the third quarter. Amundi Pioneer Asset Management Inc. now owns 1,252,938 shares of the medical device company’s stock worth $297,084,000 after purchasing an additional 26,688 shares in the last quarter. Westfield Capital Management Co. LP grew its stake in Cooper Companies by 47.8% in the third quarter. Westfield Capital Management Co. LP now owns 636,882 shares of the medical device company’s stock worth $151,011,000 after purchasing an additional 206,003 shares in the last quarter. Finally, UBS Asset Management Americas Inc. grew its stake in Cooper Companies by 12.0% in the fourth quarter. UBS Asset Management Americas Inc. now owns 558,683 shares of the medical device company’s stock worth $121,726,000 after purchasing an additional 59,857 shares in the last quarter. 97.45% of the stock is currently owned by institutional investors.
In other Cooper Companies news, Director A Thomas Bender sold 9,150 shares of the stock in a transaction on Monday, December 18th. The stock was sold at an average price of $229.17, for a total transaction of $2,096,905.50. Following the sale, the director now owns 11,205 shares of the company’s stock, valued at approximately $2,567,849.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gary S. Petersmeyer sold 785 shares of the stock in a transaction on Friday, December 15th. The shares were sold at an average price of $229.06, for a total value of $179,812.10. The disclosure for this sale can be found here. Insiders have sold a total of 54,385 shares of company stock worth $12,289,463 in the last ninety days. Insiders own 1.60% of the company’s stock.
Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.64 by $0.01. The business had revenue of $561.50 million for the quarter, compared to analysts’ expectations of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter last year, the firm earned $2.28 EPS. equities research analysts forecast that Cooper Companies Inc will post 11.6 earnings per share for the current fiscal year.
The business also recently announced a semiannual dividend, which was paid on Friday, February 9th. Shareholders of record on Tuesday, January 23rd were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Monday, January 22nd. This represents a yield of 0.03%. Cooper Companies’s dividend payout ratio (DPR) is presently 0.80%.
COO has been the topic of several research analyst reports. Stifel Nicolaus reissued a “buy” rating and issued a $265.00 price objective (down previously from $275.00) on shares of Cooper Companies in a research note on Friday, December 8th. Oppenheimer set a $250.00 price objective on Cooper Companies and gave the stock a “hold” rating in a research note on Friday, December 8th. Zacks Investment Research cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Monday, January 8th. Raymond James Financial reissued a “buy” rating and issued a $265.00 price objective on shares of Cooper Companies in a research note on Monday, December 4th. Finally, Cleveland Research cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Friday, February 9th. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Cooper Companies has a consensus rating of “Hold” and an average target price of $259.70.
TRADEMARK VIOLATION NOTICE: This story was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.watchlistnews.com/cooper-companies-inc-coo-shares-sold-by-eaton-vance-management/1909056.html.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.